---
figid: PMC8800342__13287_2022_2719_Fig1_HTML
figtitle: Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen
  receptor (CAR) for tumor immunotherapy; recent progress
organisms:
- Human alphaherpesvirus 1
- Mouse mammary tumor virus
- Human betaherpesvirus 5
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Mus musculus
pmcid: PMC8800342
filename: 13287_2022_2719_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8800342/figure/Fig1/
number: F1
caption: HER2 signaling pathway. HER2 and other EGFR family members as receptor tyrosine
  kinases positioned on the cell membrane can responds to various ligands. Phosphorylation
  of the tyrosine kinase domain in the cytoplasm instigates subsequent oncogenic signaling
  axes, such as PI3K/AKT pathway and Ras/MAPK pathway. Human epidermal growth factor
  receptor 2 (HER2), Phosphoinositide 3-kinase (PI3K), Mitogen-activated protein kinase
  (MAPK), Mammalian target of rapamycin complex (mTORC), BCL2 associated agonist of
  cell death (BAD), Nuclear factor kappa-light-chain-enhancer of activated B cells
  (NF-κB), inhibitor of nuclear factor kappa (IκBα), B-cell lymphoma-extra-large (Bcl-xL),
  Mitogen-activated protein kinase (MAP2K or MEK), MEK kinase (MEKK), Stress activated
  protein kinases (SAPKs), cAMP-response element binding protein (CREB), Cyclooxygenase-2
  (COX-2), Hypoxia-inducible factor-1 (HIF-1), Protein kinase C (PKC), Phospholipase
  C gamma (PLCγ), Diacyl glycerol (DAG), Inositol 1,4,5-trisphosphate (IP3), Vascular
  endothelial growth factor (VEGF), Epidermal growth factor receptor (EGFR)
papertitle: Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen
  receptor (CAR) for tumor immunotherapy; recent progress.
reftext: Hendrik Setia Budi, et al. Stem Cell Res Ther. 2022;13:40.
year: '2022'
doi: 10.1186/s13287-022-02719-0
journal_title: Stem Cell Research & Therapy
journal_nlm_ta: Stem Cell Res Ther
publisher_name: BioMed Central
keywords: Chimeric antigen receptor (CAR) | Human epidermal growth factor receptor
  2 (HER2) | CAR-T cell | Solid tumors | Tumor microenvironment (TME)
automl_pathway: 0.9428058
figid_alias: PMC8800342__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8800342__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8800342__13287_2022_2719_Fig1_HTML.html
  '@type': Dataset
  description: HER2 signaling pathway. HER2 and other EGFR family members as receptor
    tyrosine kinases positioned on the cell membrane can responds to various ligands.
    Phosphorylation of the tyrosine kinase domain in the cytoplasm instigates subsequent
    oncogenic signaling axes, such as PI3K/AKT pathway and Ras/MAPK pathway. Human
    epidermal growth factor receptor 2 (HER2), Phosphoinositide 3-kinase (PI3K), Mitogen-activated
    protein kinase (MAPK), Mammalian target of rapamycin complex (mTORC), BCL2 associated
    agonist of cell death (BAD), Nuclear factor kappa-light-chain-enhancer of activated
    B cells (NF-κB), inhibitor of nuclear factor kappa (IκBα), B-cell lymphoma-extra-large
    (Bcl-xL), Mitogen-activated protein kinase (MAP2K or MEK), MEK kinase (MEKK),
    Stress activated protein kinases (SAPKs), cAMP-response element binding protein
    (CREB), Cyclooxygenase-2 (COX-2), Hypoxia-inducible factor-1 (HIF-1), Protein
    kinase C (PKC), Phospholipase C gamma (PLCγ), Diacyl glycerol (DAG), Inositol
    1,4,5-trisphosphate (IP3), Vascular endothelial growth factor (VEGF), Epidermal
    growth factor receptor (EGFR)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hif1a
  - Vegfa
  - Ptgs2
  - Kcnh8
  - Ephb1
  - Raf1
  - Mdk
  - Mak
  - Alpk3
  - Myc
  - Nol3
  - ras
  - Hras
  - Kras
  - Rem1
  - Creb1
  - Map3k1
  - Epha4
  - Jun
  - Erbb2
  - Nfkbib
  - Pik3r1
  - Nfkb1
  - Akt1
  - Bad
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - sima
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - COX2
  - Elk
  - Raf
  - Dsor1
  - Mtk
  - mapP
  - CG42366
  - mle
  - E(spl)malpha-BFM
  - Ras64B
  - Ras85D
  - CrebB
  - CrebA
  - Mekk1
  - Jra
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dif
  - dl
  - Rel
  - Akt
  - cass
  - Crtc
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HIF1A
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - TGFA
  - PTGS2
  - EPHB1
  - KCNH8
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SGSM3
  - MAK
  - ALPK3
  - MYC
  - KRAS
  - HRAS
  - NRAS
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAP3K1
  - EPHA4
  - MAPK9
  - JUN
  - JUNB
  - JUND
  - ERBB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - BAD
---
